These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26962702)

  • 41. Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.
    Bamford A; Manno EC; Mellado MJ; Spoulou V; Marques L; Scherpbier HJ; Niehues T; Oldakowska A; Rossi P; Palma P;
    Vaccine; 2016 Nov; 34(46):5587-5594. PubMed ID: 27727030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.
    Goto H; Kaneko T; Shioda Y; Kajiwara M; Sakashita K; Kitoh T; Hayakawa A; Miki M; Kato K; Ogawa A; Hashii Y; Inukai T; Kato C; Sakamaki H; Yabe H; Suzuki R; Kato K
    Pediatr Blood Cancer; 2015 Jan; 62(1):148-52. PubMed ID: 25262825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome.
    Zama D; Gasperini P; Berger M; Petris M; De Pasquale MD; Cesaro S; Guerzoni ME; Mastrodicasa E; Savina F; Ziino O; Kiren V; Muggeo P; Mura RM; Melchionda F; Zanazzo GA;
    Eur J Haematol; 2018 Jan; 100(1):75-82. PubMed ID: 29032616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
    National Center for Immunization and Respiratory Diseases
    MMWR Recomm Rep; 2011 Jan; 60(2):1-64. PubMed ID: 21293327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health-Related Quality of Life among Children and Adolescents during Hematopoietic Stem Cell Transplant Recovery.
    Rodgers C; Wills-Bagnato P; Sloane R; Hockenberry M
    J Pediatr Oncol Nurs; 2015; 32(5):329-36. PubMed ID: 25592668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein intake and requirements in children and adolescents undergoing Hematopoietic Stem Cell Transplant (HSCT): An international benchmarking survey and a scoping review.
    Liu K; Sharma P; Bartle J; Gilbertson H; Cole T; McCarthy M
    Clin Nutr ESPEN; 2024 Oct; 63():274-282. PubMed ID: 38972038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
    Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
    Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.
    Kamboj M; Shah MK
    Infect Dis Clin North Am; 2019 Jun; 33(2):593-609. PubMed ID: 31005140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?
    Conrad A; Alcazer V; Valour F; Ader F;
    Expert Rev Vaccines; 2018 Apr; 17(4):299-309. PubMed ID: 29561216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Bregante S; Berisso G; Mordini N; Incagliato M; Fugazza G; Sessarego M; Bacigalupo A
    Haematologica; 1998 Oct; 83(10):896-903. PubMed ID: 9830798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers.
    Falcon CP; Broglie L; Phelan R; Choi SW; Auletta JJ; Chewning JH
    Pediatr Transplant; 2020 Dec; 24(8):e13821. PubMed ID: 32844543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
    Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study.
    Sandler ES; Homans A; Mandell L; Amylon M; Wall DA; Devidas M; Buchanan GR; Lipton JM; Billett AL
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):210-5. PubMed ID: 16679917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant.
    Wun CM; Piao Z; Hong KT; Choi JY; Hong CR; Park JD; Park KD; Shin HY; Kang HJ
    Int Immunopharmacol; 2017 Feb; 43():62-69. PubMed ID: 27960128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
    Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
    Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.